Xuefei Tan

This inventor holds 26 USPTO granted patents and 21 published patent applications, plus 9 CIPO patents and 33 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Hoffmann-La Roche Inc., Huawei Technologies Co., Limited, Agios Pharmaceuticals, Inc.. Active years: 2011-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuefei Tan. Retrieved from https://idiyas.com/inventor/xuefei-tan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 21)

% Patents Active = 88.5

CIPO Patents = 9 (Patent Applications = 1)

EPO Patents = 33 (Patent Applications = 44)

Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 35(Granted Patents)

Location History:

Shenzhen, CN (2011 - 2012)
Shanghai, CH (2015)
Beijing, CN (2015)
Shanghai, CN (2015 - 2024)

Company Filing History:

21 out of 5,026

Hoffmann-La Roche Inc.

patents

3 out of 27,557

Huawei Technologies Co., Limited

patents

2 out of 99

Agios Pharmaceuticals, Inc.

patents

Years Active: 2011-2024

Loading Chart...

Areas of Expertise:

Flavone Compounds

Chromen-4-One Derivatives

Pyrido[2,3-B]Indole

Aldosterone Synthase Inhibitors

Dihydroquinoline

Cancer Treatment

Hepatitis B

Inhibitors of IDH1

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12012390 - Flavone compounds for the treatment and prophylaxis of hepatitis B virus disease (2024-06-18),

2. 11993591 - Chromen-4-one derivatives for the treatment and prophylaxis of hepatitis B virus disease (2024-05-28),

3. 10662203 - Pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection (2020-05-26),

4. 10611748 - Xanthone derivatives for the treatment of hepatitis B virus disease (2020-04-07),

5. 10035804 - Spirodiamine derivatives as aldosterone synthase inhibitors (2018-07-31),

6. 9856279 - Therapeutically active compositions and their methods of use (2018-01-02),

7. 9796726 - Dihydroquinoline pyrazolyl compounds (2017-10-24),

8. 9796702 - Dihydroquinoline pyrazolyl compounds (2017-10-24),

9. 9790217 - Pyridinyloxy- and phenyloxy-pyrazolyl compounds (2017-10-17),

10. 9790200 - Dihydroquinoline pyrazolyl compounds (2017-10-17),

11. 9695152 - 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds (2017-07-04),

12. 9695151 - 3,4-dihydro-2H-isoquinoline-1-one and 2,3-dihydro-isoindol-1-one compounds (2017-07-04),

13. 9662327 - Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer (2017-05-30),

14. 9636339 - Phenyl-dihydropyridine derivatives as aldosterone synthase inhibitors (2017-05-02),

15. 9636338 - Phenyl-dihydropyridine derivatives as inhibitors of aldosterone synthase (2017-05-02),

Title: Xuefei Tan - Innovative Inventor from Shanghai

Introduction: Xuefei Tan is a pioneering inventor hailing from Shanghai, China, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xuefei Tan holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her commitment to creating a more efficient and eco-friendly world.

Career Highlights: With a career spanning over two decades, Xuefei Tan has worked with leading research institutions and technology companies, consistently pushing the boundaries of what is possible in the realm of innovation.

Collaborations: Xuefei Tan has collaborated with top universities and multinational corporations on various projects, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: Xuefei Tan's dedication to innovation and her relentless pursuit of technological advancement make her a true trailblazer in the world of inventors, leaving a lasting impact on the landscape of modern technology.

Profile summary based on public USPTO records.